Overview
Gotaro Yamada practices practicing medicine in Okayama, Japan.
Their clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Hepatitis, Hepatitis B, and Cirrhosis.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Gotaro Yamada
Is Gotaro Yamada a top-rated expert for Non-Alcoholic Fatty Liver Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Gotaro Yamada is classified as an Experienced expert for Non-Alcoholic Fatty Liver Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Gotaro Yamada participate in research or clinical trials?
Yes. Gotaro Yamada has published 10 articles and abstracts on conditions like Non-Alcoholic Fatty Liver Disease. You can view a list of Gotaro Yamada's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- CirrhosisYamada isExperienced. Learn about Cirrhosis.
- HepatitisYamada isExperienced. Learn about Hepatitis.
- Hepatitis BYamada isExperienced. Learn about Hepatitis B.
- Liver CancerYamada isExperienced. Learn about Liver Cancer.
- Non-Alcoholic Fatty Liver Disease
- Nonalcoholic Steatohepatitis (NASH)